Developer docs
API playgroundTry for free, no card

Search company profiles

CEDIC

Full company profile

uuid0043tjc

Namestring
CEDIC
Legal namestring
Centro para el Desarrollo de Investigación Científica
Websiteurl
cedic.org.py
Company typeenum
Private
Founded yearint
2008
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAsunción, Paraguay
HQ citystring
Asunción
HQ countrystring
Paraguay
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical research services, molecular diagnostics, preclinical drug development, biodiversity research, disease vector control
Industry2 codes
PRIMARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
NAICS code2 codes
  • Medical Laboratories621511
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Biomedical Research Services
Social media profiles2 records
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CEDIC is a non-profit research center that provides shared laboratory infrastructure and research platforms for independent researchers working in biological sciences, health, and environment. Its services span molecular diagnostics, biobank services, preclinical drug development, antivenom production, and applied research on disease vectors and zoonotic diseases in collaboration with Paraguay's Ministry of Public Health and Social Welfare (MSPBS).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 85% of world population depends directly on plants for medicine
+2 more records
Product overview1 text field

CEDIC is a non-profit research center (legally established in 2008) that operates as a research infrastructure provider rather than a traditional product company. The organization offers a unified portfolio of scientific research services centered on its laboratory infrastructure platform, including molecular diagnostic testing services for genetic diseases and cancer, biobank services developed in partnership with Galatea Bio, preclinical drug development services with pharmacological screening capabilities, and antivenom production. These services support independent researchers through various affiliation modalities, enabling work in existing or new research lines focused on the health-environment nexus.

Product and service1 record
1Molecular Diagnostic Testing Services
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Project 'Strengthening MSPBS in global fight against Chagas disease' with EU 30,000 funding for one year. Also collaborating on diagnostic validation methodologies.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Validation of alternative diagnostic methodologies: rapid tests and Chagas-LAMP for detection of chronic and congenital Trypanosoma cruzi infection.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multiple international projects including research on Triatoma infestans reinfestation in Paraguayan Chaco indigenous housing, and Chagas disease vector sources.

4Universidad de Bath (UK)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Development of genomics toolkit for Chagas Disease surveillance and digital parasitology with open robotic microscopes (Dr Richard Bowman). EU 25,000 funding for publication.

cedicpy.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Social Networks research project 2008-2010, and genetic diversity analysis of Mycobacterium tuberculosis in Paraguayan Chaco (School of Human Evolution and Social Change, 2010-2014).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint study with Universidad Nacional del Este on COVID-19 and long COVID genetic architecture in Paraguayan population. Galatea Bio (Stanford-affiliated) is developing integrated biobank platform, genomic testing, and advanced analysis capabilities in Paraguay.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Automated detection of Triatoma infestans reinfestation project (2012-2014).

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Project improving water access for six indigenous communities through autonomous and sustainable systems in Caazapa and Canindeyú, Paraguay.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Regional cooperation for promotion of Chagas disease control in the Gran Chaco Sudamericano region.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

Argentina's national research council supporting biomedical, health, and environmental research across multiple institutes. Comparable as a Latin American public research funding and infrastructure body, though operating at a national-council scale rather than a single research center like CEDIC.

2Instituto Butantan
TypeDirect peer
Description

Brazilian biomedical research institute that operates biotechnological antivenom production, molecular diagnostics, and tropical disease research—directly comparable to CEDIC's antivenom and Chagas/Leishmaniasis programs. Both serve public health missions with similar laboratory infrastructure and translational research models.

TypeDirect peer
Description

Barcelona-based global health research institute with major programs in Chagas disease and Latin American infectious disease research. ISGlobal is both a CEDIC partner and a direct peer in Chagas diagnostics development and tropical disease translational research.

4Swiss Tropical and Public Health Institute (Swiss TPH)
TypeBroad incumbent
Description

Leading European tropical and public health research institute with global programs in Chagas disease, Leishmaniasis, and neglected tropical disease diagnostics. Comparable disease focus to CEDIC but operates at much larger institutional scale with broader global footprint.

TypeDirect peer
Description

Colombian non-profit biomedical research center focused on infectious diseases of poverty, including Leishmaniasis and Chagas disease. Closely comparable to CEDIC in mission, tropical disease focus, and Latin American non-profit research center structure.

TypeBroad incumbent
Description

Brazil's primary public health and biomedical research foundation, conducting tropical disease research, diagnostic development, and reference laboratory services across South America. Comparable in mission and disease focus to CEDIC but operates at dramatically larger scale.

TypeBroad incumbent
Description

Major UK-based global health and tropical medicine research institution with extensive Chagas disease and Latin American research programs. Comparable research focus to CEDIC but operates as a globally ranked university and research institution rather than a regional non-profit.

TypeDirect peer
Description

Uruguayan biomedical research institute within the Institut Pasteur international network, focused on infectious disease research, molecular biology, and vaccine development. Directly comparable to CEDIC in South American non-profit biomedical research center structure and tropical disease focus.

TypeBroad incumbent
Description

German tropical medicine research institute conducting molecular diagnostics, parasitology, and infectious disease research including Chagas disease. Comparable research lines to CEDIC but at significantly larger scale with broader global mandate.

TypeDirect peer
Description

Panamanian biomedical and tropical disease research institute operating as a regional reference laboratory for Central America. Comparable to CEDIC as a Latin American non-profit research center with tropical disease diagnostics and biodiversity research lines.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CEDIC

Biomedical Research Servicescedic.org.py

CEDIC firmographics

Firmographics
Name
CEDIC
Legal name
Centro para el Desarrollo de Investigación Científica
Website
https://cedic.org.py
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

CEDIC industry classification

Industry
Product category
Biomedical Research Services
NAICS
Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs

Keywords

  • Biomedical research services
  • Molecular diagnostics
  • Preclinical drug development
  • Biodiversity research
  • Disease vector control

Where CEDIC is headquartered

Location

Headquarters

HQ city
Asunción
HQ country
Paraguay
HQ region
Latin America

Offices1 record

Markets served

CEDIC business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

Distribution channels2 records

Marketing channels4 records

CEDIC product offering

Product offering

Core offering

CEDIC is a non-profit research center that provides shared laboratory infrastructure and research platforms for independent researchers working in biological sciences, health, and environment. Its services span molecular diagnostics, biobank services, preclinical drug development, antivenom production, and applied research on disease vectors and zoonotic diseases in collaboration with Paraguay's Ministry of Public Health and Social Welfare (MSPBS).

Product overview

CEDIC is a non-profit research center (legally established in 2008) that operates as a research infrastructure provider rather than a traditional product company. The organization offers a unified portfolio of scientific research services centered on its laboratory infrastructure platform, including molecular diagnostic testing services for genetic diseases and cancer, biobank services developed in partnership with Galatea Bio, preclinical drug development services with pharmacological screening capabilities, and antivenom production. These services support independent researchers through various affiliation modalities, enabling work in existing or new research lines focused on the health-environment nexus.

Differentiator

Problem solved

Functional benefit

Products and services

  • Molecular Diagnostic Testing Services

Quantifiable outcome

  • 85% of world population depends directly on plants for medicine
  • +2 more outcomes

Companies that use CEDIC

Customer profile

Segments1 record

Ideal customer profiles2 records

CEDIC technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

CEDIC partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and major.

  • ISGlobal / AECIDcoreStrategic or Co-development Partner · 1 January 2021Project 'Strengthening MSPBS in global fight against Chagas disease' with EU 30,000 funding for one year. Also collaborating on diagnostic validation methodologies.
  • GHIT Fund / Fundación Mundo SanocoreStrategic or Co-development Partner · 1 January 2021Validation of alternative diagnostic methodologies: rapid tests and Chagas-LAMP for detection of chronic and congenital Trypanosoma cruzi infection.
  • UNICEF / UNDP / World Bank / WHO TDRcoreStrategic or Co-development PartnerMultiple international projects including research on Triatoma infestans reinfestation in Paraguayan Chaco indigenous housing, and Chagas disease vector sources.
  • Universidad de Bath (UK)coreStrategic or Co-development PartnerDevelopment of genomics toolkit for Chagas Disease surveillance and digital parasitology with open robotic microscopes (Dr Richard Bowman). EU 25,000 funding for publication.
  • Arizona State UniversitycoreStrategic or Co-development PartnerSocial Networks research project 2008-2010, and genetic diversity analysis of Mycobacterium tuberculosis in Paraguayan Chaco (School of Human Evolution and Social Change, 2010-2014).
  • Galatea BiocoreStrategic or Co-development PartnerJoint study with Universidad Nacional del Este on COVID-19 and long COVID genetic architecture in Paraguayan population. Galatea Bio (Stanford-affiliated) is developing integrated biobank platform, genomic testing, and advanced analysis capabilities in Paraguay.
  • Universitat de les Illes BalearsmajorStrategic or Co-development PartnerAutomated detection of Triatoma infestans reinfestation project (2012-2014).
  • Fundación Moises BertonimajorStrategic or Co-development PartnerProject improving water access for six indigenous communities through autonomous and sustainable systems in Caazapa and Canindeyú, Paraguay.
  • BID / Mundo Sano / SENEPAmajorStrategic or Co-development PartnerRegional cooperation for promotion of Chagas disease control in the Gran Chaco Sudamericano region.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

CEDIC competitors and assessment

Company assessment

Regional players

  • CONICET (Argentina): Argentina's national research council supporting biomedical, health, and environmental research across multiple institutes. Comparable as a Latin American public research funding and infrastructure body, though operating at a national-council scale rather than a single research center like CEDIC.

Direct peers

  • Instituto Butantan: Brazilian biomedical research institute that operates biotechnological antivenom production, molecular diagnostics, and tropical disease research—directly comparable to CEDIC's antivenom and Chagas/Leishmaniasis programs. Both serve public health missions with similar laboratory infrastructure and translational research models.
  • ISGlobal (Barcelona Institute for Global Health): Barcelona-based global health research institute with major programs in Chagas disease and Latin American infectious disease research. ISGlobal is both a CEDIC partner and a direct peer in Chagas diagnostics development and tropical disease translational research.
  • CIDEIM (Centro Internacional de Entrenamiento e Investigaciones Médicas): Colombian non-profit biomedical research center focused on infectious diseases of poverty, including Leishmaniasis and Chagas disease. Closely comparable to CEDIC in mission, tropical disease focus, and Latin American non-profit research center structure.
  • Institut Pasteur de Montevideo: Uruguayan biomedical research institute within the Institut Pasteur international network, focused on infectious disease research, molecular biology, and vaccine development. Directly comparable to CEDIC in South American non-profit biomedical research center structure and tropical disease focus.
  • Instituto Gorgas de Estudios de la Salud: Panamanian biomedical and tropical disease research institute operating as a regional reference laboratory for Central America. Comparable to CEDIC as a Latin American non-profit research center with tropical disease diagnostics and biodiversity research lines.

Broad incumbents

  • Swiss Tropical and Public Health Institute (Swiss TPH): Leading European tropical and public health research institute with global programs in Chagas disease, Leishmaniasis, and neglected tropical disease diagnostics. Comparable disease focus to CEDIC but operates at much larger institutional scale with broader global footprint.
  • Fiocruz (Fundação Oswaldo Cruz): Brazil's primary public health and biomedical research foundation, conducting tropical disease research, diagnostic development, and reference laboratory services across South America. Comparable in mission and disease focus to CEDIC but operates at dramatically larger scale.
  • London School of Hygiene & Tropical Medicine: Major UK-based global health and tropical medicine research institution with extensive Chagas disease and Latin American research programs. Comparable research focus to CEDIC but operates as a globally ranked university and research institution rather than a regional non-profit.
  • Bernhard Nocht Institute for Tropical Medicine: German tropical medicine research institute conducting molecular diagnostics, parasitology, and infectious disease research including Chagas disease. Comparable research lines to CEDIC but at significantly larger scale with broader global mandate.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

CEDIC social profiles

Digital presence

CEDIC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CEDIC leadership team

Management profile

Number of profiles

CEDIC funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CEDIC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CEDIC

What does CEDIC do?

CEDIC is a non-profit research center that provides shared laboratory infrastructure and research platforms for independent researchers working in biological sciences, health, and environment. Its services span molecular diagnostics, biobank services, preclinical drug development, antivenom production, and applied research on disease vectors and zoonotic diseases in collaboration with Paraguay's Ministry of Public Health and Social Welfare (MSPBS).

Is CEDIC a public or private company?

CEDIC is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was CEDIC founded?

CEDIC was founded in 2008. It employs 11 to 50 people.

Where is CEDIC based?

CEDIC is headquartered in Asunción, Paraguay, in the Latin America region.

Who are CEDIC's main competitors?

CONICET (Argentina) is listed as a regional player. Direct peers are Instituto Butantan, ISGlobal (Barcelona Institute for Global Health), CIDEIM (Centro Internacional de Entrenamiento e Investigaciones Médicas), Institut Pasteur de Montevideo and Instituto Gorgas de Estudios de la Salud. Broad incumbents are Swiss Tropical and Public Health Institute (Swiss TPH), Fiocruz (Fundação Oswaldo Cruz), London School of Hygiene & Tropical Medicine and Bernhard Nocht Institute for Tropical Medicine.

Does CEDIC have an API?

No public API is recorded for CEDIC.

What industry is CEDIC in?

CEDIC's product category is Biomedical Research Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales